Health Care & Life Sciences » Pharmaceuticals | Bellerophon Therapeutics Inc.

Bellerophon Therapeutics Inc. | Key People and Executives

Jonathan M. Peacock
Chairman
Fabian Tenenbaum
Chief Executive Officer & Director
Daniel Tassé
Director
Matthew M. Bennett
Independent Director
Theodore Wang
Independent Director
Mary Ann Cloyd
Independent Director
Naseem Amin
Independent Director
Scott P. Bruder
Independent Director
Andre V. Moura
Independent Director
Jens Luehring
Independent Director
Jonathan M. Peacock
Chairman
Fabian Tenenbaum
Chief Executive Officer & Director
Assaf Korner
Chief Financial Officer & Secretary
Amy Edmonds
VP-Clinical Operations & Administration
Deborah A. Quinn
Chief Medical Officer
Martin Dekker
Vice President-Device Engineering & Supply
Daniel Tassé
Director
Peter Fernandes
Chief Regulatory & Safety Officer
Matthew M. Bennett
Independent Director
Theodore Wang
Independent Director
Mary Ann Cloyd
Independent Director
Naseem Amin
Independent Director
Scott P. Bruder
Independent Director
Andre V. Moura
Independent Director
Jens Luehring
Independent Director

About Bellerophon Therapeutics

View Profile
Address
184 Liberty Corner Road
Warren New Jersey 07059
United States
Employees -
Website http://www.bellerophon.com
Updated 07/08/2019
Bellerophon Therapeutics, Inc clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.